Cargando…

High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy

Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivelä, A. M., Huusko, J., Gurzeler, E., Laine, A., Dijkstra, M. H., Dragneva, G., Andersen, C. B. F., Moestrup, S. K., Ylä-Herttuala, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428218/
https://www.ncbi.nlm.nih.gov/pubmed/28341860
http://dx.doi.org/10.1038/s41598-017-00376-5
_version_ 1783235767033659392
author Kivelä, A. M.
Huusko, J.
Gurzeler, E.
Laine, A.
Dijkstra, M. H.
Dragneva, G.
Andersen, C. B. F.
Moestrup, S. K.
Ylä-Herttuala, S.
author_facet Kivelä, A. M.
Huusko, J.
Gurzeler, E.
Laine, A.
Dijkstra, M. H.
Dragneva, G.
Andersen, C. B. F.
Moestrup, S. K.
Ylä-Herttuala, S.
author_sort Kivelä, A. M.
collection PubMed
description Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly decrease adenoviral transduction efficiency in vivo. Here we demonstrate that mice on a high fat diet have lower transgene expression compared to mice on a regular chow. In addition, on a high fat diet, ApoE(−/−) mice have much higher plasma transgene levels compared to LDLR-deficient mice. We also found that specific lipoprotein receptors play an important role in adenoviral transduction. These findings suggest that high plasma lipid levels, especially apoE-containing lipoproteins, reduce efficacy of adenoviral transduction in mice, which implies that high cholesterol levels in humans could be protective against viral infections and also lead to insufficient transgene expression in clinical trials using adenoviral vectors.
format Online
Article
Text
id pubmed-5428218
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54282182017-05-15 High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy Kivelä, A. M. Huusko, J. Gurzeler, E. Laine, A. Dijkstra, M. H. Dragneva, G. Andersen, C. B. F. Moestrup, S. K. Ylä-Herttuala, S. Sci Rep Article Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly decrease adenoviral transduction efficiency in vivo. Here we demonstrate that mice on a high fat diet have lower transgene expression compared to mice on a regular chow. In addition, on a high fat diet, ApoE(−/−) mice have much higher plasma transgene levels compared to LDLR-deficient mice. We also found that specific lipoprotein receptors play an important role in adenoviral transduction. These findings suggest that high plasma lipid levels, especially apoE-containing lipoproteins, reduce efficacy of adenoviral transduction in mice, which implies that high cholesterol levels in humans could be protective against viral infections and also lead to insufficient transgene expression in clinical trials using adenoviral vectors. Nature Publishing Group UK 2017-03-24 /pmc/articles/PMC5428218/ /pubmed/28341860 http://dx.doi.org/10.1038/s41598-017-00376-5 Text en © The Author(s) 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Kivelä, A. M.
Huusko, J.
Gurzeler, E.
Laine, A.
Dijkstra, M. H.
Dragneva, G.
Andersen, C. B. F.
Moestrup, S. K.
Ylä-Herttuala, S.
High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title_full High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title_fullStr High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title_full_unstemmed High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title_short High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
title_sort high plasma lipid levels reduce efficacy of adenovirus-mediated gene therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428218/
https://www.ncbi.nlm.nih.gov/pubmed/28341860
http://dx.doi.org/10.1038/s41598-017-00376-5
work_keys_str_mv AT kivelaam highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT huuskoj highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT gurzelere highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT lainea highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT dijkstramh highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT dragnevag highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT andersencbf highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT moestrupsk highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy
AT ylaherttualas highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy